Fifty-four years after the publication of Rachel Carson’s clarion call, against a Silent Spring, the pesticide sector of the agricultural industry is vastly energized by genetically engineered (GE) food crops. Behemoth monopolies are being forged by biotech corporate rogues who have deluged the farming . . . Continue reading →
Scientists and entrepreneurs have tried for years to develop a safe and universal blood substitute that did not spoil after 42 days. However, all such efforts have encountered serious safety problems.
Continue reading →
UK Patients Used as Drug ‘Guinea Pigs”_Guardian Feb 9 2003 Medical fraud experts in the U.K. estimate that one per cent of all drug trials involve fraud, including failure to get proper consent from patients. An investigation by The Guardian / Observer . . . Continue reading →
FDA, a complicit partner in crimes and corrupt industry practices have resulted in an epidemic of preventable injuries and deaths. Continue reading →
On Friday, April 6, the FDA approved another of Eli Lilly’s "breakthroughs" whose clinical value is questionable (at best). Continue reading →
100 Amgen scientists were astonished to find that they were able to replicate the results of only 6 of 53 widely cited landmark cancer research papers.
Continue reading →
This year alone, because of patent expirations, the drug industry will lose control over more than 10 megamedicines whose combined annual sales have neared $50 billion.
The Coalition Against Bayer pharmaceuticals (CBG) announces that Bayer and Baxter settled a mulit-million dollar compensation suit with hemophiliacs in 22 countries who were victims, infected with HIV or hepatitis C having been infused with tainted blood plasma products in the 1980s. . . . Continue reading →
"500 people would need to be treated with Crestor for a year to avoid one usually survivable heart attack. Stroke numbers were similar…At $3.50 a pill, the cost of prescribing Crestor to 500 people for a year would be $638,000 to prevent one heart attack." Continue reading →
Overshadowing all other health related news, a front page report in The Washington Post and the just released Breckenridge report evaluating FDA's abysmal performance on drug safety, http://ahrp.blogspot.com/2007/03/latest-report-blasts-fda-bungling-drug.html require Congressional action.
Continue reading →
Repeat legal violations: The record of recidivism by major drug manufacturers is a matter of public record.
Continue reading →
FDA's slip-shod approval of defective, harmful drugs, accompanied by rubber stampped endorsements by compromised FDA advisory committees may be reaching a boiling point.
Continue reading →
